Novel coronavirus neutralizing antibody determination kit

A coronavirus and kit technology, applied in the field of new coronavirus neutralizing antibody assay kits, can solve problems such as unclear, unfavorable transportation of reagents, complicated manual operation steps, etc.

Inactive Publication Date: 2021-07-06
DIRUI MEDICAL TECH CO LTD
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, how long it takes for neutralizing antibodies to be produced, and whether they are always produced after 2019-nCoV infection, is unclear
At present, Chinese patent 202010919164.X provides an ELISA kit for the detection of neutralizing antibody titer of novel coronavirus. The ELISA detection method requires operational steps such as sealing, color development and termination and related reagents. The detection time is long and the manual operation steps are complicated. The variety of reagents is not conducive to transportation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel coronavirus neutralizing antibody determination kit
  • Novel coronavirus neutralizing antibody determination kit
  • Novel coronavirus neutralizing antibody determination kit

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Preparation and stability evaluation of the novel coronavirus neutralizing antibody assay kit:

[0029] 1. Preparation of R1 reagent

[0030] Take the streptavidin magnetic particle solution, add TBST solution and mix well, place it on a magnetic separator until the supernatant is free of turbidity, discard the supernatant, keep the magnetic particles, repeat washing 3 times, and dilute with magnetic beads The streptavidin magnetic particle solution was obtained after dilution with the buffer solution, and the concentration was 0.072%.

[0031] 2. Preparation of R2 reagent

[0032] 2.1 Preparation of novel coronavirus S protein RBD labeled with chemiluminescent substances:

[0033] Take 0.5 mg of the novel coronavirus S protein RBD, and use a 10KDa ultrafiltration centrifuge tube for ultrafiltration and centrifugation, and replace the raw material buffer with the labeling buffer, the centrifuge speed is 9000rpm, and the centrifugation time is 30min. The raw material ...

Embodiment 2

[0054] Preparation and stability evaluation of the novel coronavirus neutralizing antibody assay kit:

[0055] 1. Preparation of R1 reagent

[0056] Take the streptavidin magnetic particle solution, add TBST solution and mix well, place it on the magnetic separator until the supernatant is free of turbidity, discard the supernatant, keep the magnetic particles, repeat washing 3 times, and dilute with magnetic beads The streptavidin magnetic particle solution was obtained after dilution with the buffer solution, and the concentration was 0.072%.

[0057] 2. Preparation of R2 reagent

[0058] 2.1 Preparation of novel coronavirus S protein RBD labeled with chemiluminescent substances:

[0059] Take 0.5 mg of the novel coronavirus S protein RBD, use a 10KDa ultrafiltration centrifuge tube for ultrafiltration and centrifugation, replace the raw material buffer with the labeling buffer, the centrifuge speed is 9000rpm, and the centrifugation time is 30min. The raw material buffer...

Embodiment 3

[0080] Preparation and stability evaluation of the novel coronavirus neutralizing antibody assay kit:

[0081] 1. Preparation of R1 reagent

[0082] Take the streptavidin magnetic particle solution, add TBST solution and mix well, place it on the magnetic separator until the supernatant is free of turbidity, discard the supernatant, keep the magnetic particles, repeat washing 3 times, and dilute with magnetic beads The streptavidin magnetic particle solution was obtained after dilution with the buffer solution, and the concentration was 0.072%.

[0083] 2. Preparation of R2 reagent

[0084] 2.1 Preparation of novel coronavirus S protein RBD labeled with chemiluminescent substances:

[0085] Take 0.5 mg of the novel coronavirus S protein RBD, use a 10KDa ultrafiltration centrifuge tube for ultrafiltration and centrifugation, replace the raw material buffer with the labeling buffer, the centrifuge speed is 9000rpm, and the centrifugation time is 30min. The raw material buffer...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
concentrationaaaaaaaaaa
concentrationaaaaaaaaaa
Login to View More

Abstract

The invention relates to a novel coronavirus neutralizing antibody determination kit, and belongs to the technical field of chemiluminiscence in-vitro diagnosis. The novel coronavirus neutralizing antibody determination kit comprises an R1 reagent which is streptavidin magnetic particles, an R2 reagent which is a novel coronavirus S protein RBD labeled by a chemiluminescent substance, an acridinium ester or an acridinium ester derivative is the chemiluminescent substance, and an R3 reagent is ACE2 labeled by biotin, a calibration product and a quality control product. The kit provided by the invention adopts a competition method to detect the novel coronavirus neutralizing antibody, the interaction between the virus and the host is simulated through the interaction between RBD protein and hACE2 protein, and the detection result can completely represent the result of the novel coronavirus neutralizing antibody. The kit provided by the invention adopts a direct chemiluminescence method for detection, has the advantages of low cost, no radioactive contamination, few reagent types, convenience in transportation, simplicity in operation and high detection speed, and can meet the large-scale clinical sample detection requirements of hospitals.

Description

technical field [0001] The invention belongs to the technical field of chemiluminescence in vitro diagnosis, and in particular relates to a novel coronavirus neutralizing antibody assay kit. Background technique [0002] 2019-nCoV belongs to the genus Coronavirus β, which is a single-stranded RNA virus that can cause acute respiratory disease (coronavirus disease-2019, COVID-19). 2019-nCoV has a variety of structural proteins, including spike protein (S), envelope protein (E), membrane protein (M) and nucleocapsid protein (N). Among these proteins, spike protein and nucleocapsid protein are the main immunogens. The S protein is a major protective antigen that can induce highly efficient neutralizing antibodies (NAbs) and plays an important role in virus attachment, fusion, entry, and transmission. The S protein contains an N-terminal S1 subunit responsible for virus-receptor binding and a C-terminal S2 subunit responsible for virus-cell membrane fusion. The S1 subunit is ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(China)
IPC IPC(8): G01N33/569G01N33/68G01N21/76
CPCG01N33/56983G01N33/6851G01N21/763G01N2333/165G01N2469/20G01N2333/948
Inventor唐仁陶胡雪凇于猛孟令敏高威孙成艳齐琳丛凡淏刘春平
OwnerDIRUI MEDICAL TECH CO LTD